Category Archives: Events

Latest From Events

How to Drive International Innovation: Scientific American Worldview

Worldview Super Session

Which countries are winning the innovation game? Will the U.S. maintain its leadership position in the future? Have emerging markets lived up to the hype? Which new partnerships are transforming industries? For the fifth year, Scientific American (SA) released their Worldview: A Global Biotechnology Perspective report at the 2013 BIO International Convention in Chicago. Included in this year’s report is the longest list of country rankings that SA has ever compiled and the numbers reveal Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

Debt, Taxes and Politics: Is There a Way Out?

Debt, Taxes and Politics: Is There a Way Out?

BIO President and CEO Jim Greenwood kicked off a keynote discussion with Sen. Alan Simpson and Erskine Bowles at the BIO International Convention, saying public policy can make or break the biotech industry’s best efforts to deliver innovations that make our world a better place, and then asked the esteemed duo if our government can make the tough choices needed to keep our economy strong. “You can’t tax your way out of this hole, you can’t cut spending your Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,

Scientific American Worldview

Scientific American Worldview

The fifth annual edition of Scientific American Worldview explores ongoing challenges and opportunities in the biopharmaceutical industry, including the looming potential of an “innovation cliff.” Many experts believe that biotechnology remains in its infancy, leaving room for growth. The overall volatility makes it difficult to accurately assess trends within individual countries, but the mission of Worldview is to create an increasingly precise picture of the evolution of biotechnology innovation around the world. One of the Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , ,

Managed Entry Trumps Risk Sharing

Since 2000, pharmaceu-tical and biotech companies have engaged in agreements with government and private payers across the world to gain market access for their innovative drugs despite struggles to qualify for formal reimbursement criteria, such as the cost effectiveness threshold from NICE in the UK. These agreements, usually referred to as “risk sharing” agreements, have had a wide variety of structures but usually do not involve any sharing of risk, as the name misleadingly suggests. Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

Natalie Ng wins the International BioGENEius Challenge

Natalie Ng

Today, Cupertino Junior Natalie Ng won the International BioGENEius Challenge, the premier competition for high school students that recognizes outstanding research in biotechnology. Natalie’s research in breast cancer and biomarkers helped her stand out from the 13 other finalists from across the U.S., Canada and Australia competing for the Challenge’s top prize, a $7,500 cash award. The winner was named during the 2013 BIO International Convention’s keynote luncheon.  The International BioGENEius Challenges is one of Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , ,